SE9903996D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9903996D0 SE9903996D0 SE9903996A SE9903996A SE9903996D0 SE 9903996 D0 SE9903996 D0 SE 9903996D0 SE 9903996 A SE9903996 A SE 9903996A SE 9903996 A SE9903996 A SE 9903996A SE 9903996 D0 SE9903996 D0 SE 9903996D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- new compounds
- nicotinic
- reductions
- enantiomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903996A SE9903996D0 (sv) | 1999-11-03 | 1999-11-03 | New compounds |
ARP000105648A AR026258A1 (es) | 1999-10-27 | 2000-10-26 | Proceso de formacion de lactonas. |
ARP000105701A AR026286A1 (es) | 1999-11-03 | 2000-10-27 | Nuevos compuestos |
JP2001534772A JP2003513072A (ja) | 1999-11-03 | 2000-11-01 | ニコチン受容体作用薬の正のモジュレーター |
PCT/SE2000/002149 WO2001032620A1 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
EP00980158A EP1230217B1 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
AT00980158T ATE305925T1 (de) | 1999-11-03 | 2000-11-01 | Positive modulatoren von nicotinrezeptor- agonisten |
US10/111,028 US6756398B1 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
CO00083138A CO5280192A1 (es) | 1999-11-03 | 2000-11-01 | Nuevos compuestos |
AU17455/01A AU1745501A (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
DE60023020T DE60023020T2 (de) | 1999-11-03 | 2000-11-01 | Positive modulatoren von nicotinrezeptor-agonisten |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903996A SE9903996D0 (sv) | 1999-11-03 | 1999-11-03 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9903996D0 true SE9903996D0 (sv) | 1999-11-03 |
Family
ID=20417606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9903996A SE9903996D0 (sv) | 1999-10-27 | 1999-11-03 | New compounds |
Country Status (10)
Country | Link |
---|---|
US (1) | US6756398B1 (sv) |
EP (1) | EP1230217B1 (sv) |
JP (1) | JP2003513072A (sv) |
AR (1) | AR026286A1 (sv) |
AT (1) | ATE305925T1 (sv) |
AU (1) | AU1745501A (sv) |
CO (1) | CO5280192A1 (sv) |
DE (1) | DE60023020T2 (sv) |
SE (1) | SE9903996D0 (sv) |
WO (1) | WO2001032620A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
SE0202598D0 (sv) * | 2002-09-02 | 2002-09-02 | Astrazeneca Ab | Alpha-7 Nicotinic receptor agonists and statins in combination |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
AU2011256287B2 (en) | 2010-05-17 | 2016-11-10 | Envivo Pharmaceuticals, Inc. | A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2731223A1 (fr) | 1995-03-02 | 1996-09-06 | Pf Medicament | Nouveaux derives bi-tryptaminiques, leur procede de preparation et leur utilisation a titre de medicaments |
CA2319174A1 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
-
1999
- 1999-11-03 SE SE9903996A patent/SE9903996D0/sv unknown
-
2000
- 2000-10-27 AR ARP000105701A patent/AR026286A1/es unknown
- 2000-11-01 WO PCT/SE2000/002149 patent/WO2001032620A1/en active IP Right Grant
- 2000-11-01 AT AT00980158T patent/ATE305925T1/de not_active IP Right Cessation
- 2000-11-01 EP EP00980158A patent/EP1230217B1/en not_active Expired - Lifetime
- 2000-11-01 DE DE60023020T patent/DE60023020T2/de not_active Expired - Fee Related
- 2000-11-01 JP JP2001534772A patent/JP2003513072A/ja not_active Abandoned
- 2000-11-01 AU AU17455/01A patent/AU1745501A/en not_active Abandoned
- 2000-11-01 US US10/111,028 patent/US6756398B1/en not_active Expired - Fee Related
- 2000-11-01 CO CO00083138A patent/CO5280192A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO5280192A1 (es) | 2003-05-30 |
AU1745501A (en) | 2001-05-14 |
ATE305925T1 (de) | 2005-10-15 |
DE60023020T2 (de) | 2006-06-14 |
WO2001032620A1 (en) | 2001-05-10 |
EP1230217A1 (en) | 2002-08-14 |
DE60023020D1 (de) | 2006-02-16 |
US6756398B1 (en) | 2004-06-29 |
AR026286A1 (es) | 2003-02-05 |
JP2003513072A (ja) | 2003-04-08 |
EP1230217B1 (en) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9903998D0 (sv) | New compounds | |
SE9903997D0 (sv) | New compounds | |
SE9903760D0 (sv) | New compounds | |
MY134568A (en) | Cb2 receptor agonists | |
ATE302775T1 (de) | Carbolinderivate | |
GB9801690D0 (en) | Therapeutic agents | |
IS6658A (is) | Ný efnasambönd | |
ATE316083T1 (de) | Adamantanderivate | |
GEP20084488B (en) | Use of therapeutic agents for treating pain | |
ATE346067T1 (de) | Carbolinderivate | |
PT1263725E (pt) | Novos compostos | |
BR0109703A (pt) | Derivados de piperazina | |
MY137156A (en) | Dual nk1/nk3 derivatives | |
SE9900961D0 (sv) | Novel compounds | |
SE0104250D0 (sv) | Heterocyclic compounds | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
MXPA02012076A (es) | Compuestos quimicos. | |
AU2001266575A1 (en) | Chemical compounds | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0101038D0 (sv) | Novel compounds | |
SE0203070D0 (en) | Novel compounds | |
AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate |